Viral Therapy of Human Cancers
Featuring contributions from nearly 30 leading authorities, this pioneering work gauges the potential for viruses to act as oncolytic and anti-tumor agents for the treatment of cancers in humans-detailing the cancer-combative properties exhibited by viruses in nature, genetically engineered viruses,...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Weitere Verfasser: | |
| Dokumenttyp: | Book/Monograph |
| Sprache: | Englisch |
| Veröffentlicht: |
Hoboken
Taylor and Francis
2004
|
| Volumes / Articles: | Show Volumes / Articles. |
| Schlagworte: | |
| Online-Zugang: | Aggregator, Volltext: https://ebookcentral.proquest.com/lib/kxp/detail.action?docID=1405275
|
MARC
| LEADER | 00000cam a22000002c 4500 | ||
|---|---|---|---|
| 001 | 79309979X | ||
| 003 | DE-627 | ||
| 005 | 20251016222913.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 140819s2004 xx |||||o 00| ||eng c | ||
| 020 | |a 9780824759131 |9 978-0-8247-5913-1 | ||
| 035 | |a (DE-627)79309979X | ||
| 035 | |a (DE-576)9793099798 | ||
| 035 | |a (DE-599)GBV79309979X | ||
| 035 | |a (EBC)EBC1405275 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC271.V567 V55 2013 | |
| 082 | 0 | |a 616.99/406 |a 616.99406 | |
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sinkovics, Joseph G. |d 1924- |0 (DE-588)136402224 |0 (DE-627)582077176 |0 (DE-576)301001634 |4 aut | |
| 245 | 1 | 0 | |a Viral Therapy of Human Cancers |
| 264 | 1 | |a Hoboken |b Taylor and Francis |c 2004 | |
| 300 | |a Online-Ressource (848 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Description based upon print version of record | ||
| 505 | 8 | |a Front cover; Preface; Contents; Contributors; Progressive Development of Viral Therapy of Human Cancers; EARLY HISTORY; VIRUSES INTERACT; FROM MICE TO MAN; POSTONCOLYTIC ANTITUMOR IMMUNITY; VIRAL ONCOLYSATES; IMMUNE REACTIONS; MORE RECENT HISTORY; VIRAL ONCOLYSIS TODAY Influenza Virus; Measles Virus; Newcastle Disease Virus; Vesicular Stomatitis Virus; Reovirus; Vaccinia Virus; Herpes Viruses; Adenoviruses; Parvoviruses; Polio-Rhinovirus Recombinants; SAFETY MEASURES AND REGULATIONS; THE FUTURE; AFTERTHOUGHTS; REFERENCES; New Biological Therapeutics; INTRODUCTION | |
| 505 | 8 | |a FARNESYL TRANSFERASE INHIBITORS c-ras*Viral Attack; Host Counterattack; Adenoviral Oncolysis; Farnsyl Transferase Inhibitors; TYROSINE KINASE INHIBITORS Imatinib Mesylate; ZD1839 Gefitinib; OSI-774 Erlotinib; PART I: RECENT DEVELOPMENTS IN VIRAL ONCOLYSIS; REFERENCES FOR INTRODUCTION AND PART I; PART II: FLAVOPIRIDOLS, PROTEIN KINASE C, METALLOPROTEINASES, AND CYCLOOXYGENASE INHIBITORS FLAVOPIRIDOLS Cyclins; Flavopiridol-Induced Apoptosis; Inhibitors; PROTEIN KINASE C INHIBITORS A Bad Kinase; Inhibitors; METALLOPROTEINASE INHIBITORS Pathophysiology; Inhibitors | |
| 505 | 8 | |a CYCLOOXYGENASE INHIBITORS EicosanoidsNonsteroidal Anti-inflammatory Agents; RECENT DEVELOPMENTS IN MOLECULAR ONCOLOGY: PARTS I AND II; REFERENCES: PART II; PART III: ANTISENSE OLIGONUCLEOTIDES AND ANTI-ANGIOGENESIS ANTISENSE OLIGONUCLEOTIDES Viral Blockade; From Anti- to Pro-Apoptosis; c-myc; ANTI-NEOANGIOGENESIS Vasculogenesis; Angiogenesis; Inhibitors of Neoangiogenesis; Monoclonal Antibodies; Antisense Technology; Vaccines; REFERENCES, PART III; PART IV. THE PREDICTIVE VALUE OF TISSUE CULTURE AND XENOGRAFT ASSAYS CULTURE SHOCK Tissue Cultures; Trypsin | |
| 505 | 8 | |a THE TELOMERES ARE GETTING SHORTER TelomeraseRapamycins, As-ODN, Lymphocytes; ONE DAY IN THE LIFE OF ''IVAN XENOGRAFTOVICH''* Paracrine Circuits; Natural Killer Cells; Insulinlike Growth Factor-R; Activated Stroma; Intercellular Adhesions; Natural Hybridomas; THE MICROVASCULAR TUMOR BED Microvasculature; Suppressors; CHEMOKINE AND CYTOKINE GROWTH FACTORS Expropriated Cytokines; Matrix Metalloproteinases and Chemokines; Mesothelioma; Catenins, Caveolins, Connexins; Autocrine Circuits; Virus-Induced Cytokines and Chemokines | |
| 505 | 8 | |a HORMONE-RELATED EVENTS IN BREAST AND PROSTATE CANCERS Complex InteractionsAstonishing Observations; MISCELLANEOUS AGENTS TESTED IN XENOGRAFTS Xenografts of Human Tumors Are Very Sensitive to Noxious and Natural Substances; Endless List of Anti-Tumor Agents and Interventions; REFERENCES, PART IV; PART V: CLINICAL EXAMPLES: MULTIPLE MYELOMA AND GLIOBLASTOMA MULTIFORME MULTIPLE MYELOMA Pathogenesis; Biotherapy; GLIOBLASTOMA MULTIFORME Pathogenesis; Biotherapy; REFERENCES, PART V; DISCUSSION; SELECTED REFERENCES; SUMMARY | |
| 505 | 8 | |a Measles Virus: Improving Natural Oncolytic Properties by Genetic Engineering | |
| 505 | 8 | |a Front cover; Preface; Contents; Contributors; Progressive Development of Viral Therapy of Human Cancers; EARLY HISTORY; VIRUSES INTERACT; FROM MICE TO MAN; POSTONCOLYTIC ANTITUMOR IMMUNITY; VIRAL ONCOLYSATES; IMMUNE REACTIONS; MORE RECENT HISTORY; VIRAL ONCOLYSIS TODAY Influenza Virus; Measles Virus; Newcastle Disease Virus; Vesicular Stomatitis Virus; Reovirus; Vaccinia Virus; Herpes Viruses; Adenoviruses; Parvoviruses; Polio-Rhinovirus Recombinants; SAFETY MEASURES AND REGULATIONS; THE FUTURE; AFTERTHOUGHTS; REFERENCES; New Biological Therapeutics; INTRODUCTION | |
| 505 | 8 | |a FARNESYL TRANSFERASE INHIBITORS c-ras*Viral Attack; Host Counterattack; Adenoviral Oncolysis; Farnsyl Transferase Inhibitors; TYROSINE KINASE INHIBITORS Imatinib Mesylate; ZD1839 Gefitinib; OSI-774 Erlotinib; PART I: RECENT DEVELOPMENTS IN VIRAL ONCOLYSIS; REFERENCES FOR INTRODUCTION AND PART I; PART II: FLAVOPIRIDOLS, PROTEIN KINASE C, METALLOPROTEINASES, AND CYCLOOXYGENASE INHIBITORS FLAVOPIRIDOLS Cyclins; Flavopiridol-Induced Apoptosis; Inhibitors; PROTEIN KINASE C INHIBITORS A Bad Kinase; Inhibitors; METALLOPROTEINASE INHIBITORS Pathophysiology; Inhibitors | |
| 505 | 8 | |a CYCLOOXYGENASE INHIBITORS EicosanoidsNonsteroidal Anti-inflammatory Agents; RECENT DEVELOPMENTS IN MOLECULAR ONCOLOGY: PARTS I AND II; REFERENCES: PART II; PART III: ANTISENSE OLIGONUCLEOTIDES AND ANTI-ANGIOGENESIS ANTISENSE OLIGONUCLEOTIDES Viral Blockade; From Anti- to Pro-Apoptosis; c-myc; ANTI-NEOANGIOGENESIS Vasculogenesis; Angiogenesis; Inhibitors of Neoangiogenesis; Monoclonal Antibodies; Antisense Technology; Vaccines; REFERENCES, PART III; PART IV. THE PREDICTIVE VALUE OF TISSUE CULTURE AND XENOGRAFT ASSAYS CULTURE SHOCK Tissue Cultures; Trypsin | |
| 505 | 8 | |a THE TELOMERES ARE GETTING SHORTER TelomeraseRapamycins, As-ODN, Lymphocytes; ONE DAY IN THE LIFE OF ''IVAN XENOGRAFTOVICH''* Paracrine Circuits; Natural Killer Cells; Insulinlike Growth Factor-R; Activated Stroma; Intercellular Adhesions; Natural Hybridomas; THE MICROVASCULAR TUMOR BED Microvasculature; Suppressors; CHEMOKINE AND CYTOKINE GROWTH FACTORS Expropriated Cytokines; Matrix Metalloproteinases and Chemokines; Mesothelioma; Catenins, Caveolins, Connexins; Autocrine Circuits; Virus-Induced Cytokines and Chemokines | |
| 505 | 8 | |a HORMONE-RELATED EVENTS IN BREAST AND PROSTATE CANCERS Complex InteractionsAstonishing Observations; MISCELLANEOUS AGENTS TESTED IN XENOGRAFTS Xenografts of Human Tumors Are Very Sensitive to Noxious and Natural Substances; Endless List of Anti-Tumor Agents and Interventions; REFERENCES, PART IV; PART V: CLINICAL EXAMPLES: MULTIPLE MYELOMA AND GLIOBLASTOMA MULTIFORME MULTIPLE MYELOMA Pathogenesis; Biotherapy; GLIOBLASTOMA MULTIFORME Pathogenesis; Biotherapy; REFERENCES, PART V; DISCUSSION; SELECTED REFERENCES; SUMMARY | |
| 505 | 8 | |a Measles Virus: Improving Natural Oncolytic Properties by Genetic Engineering | |
| 520 | |a Featuring contributions from nearly 30 leading authorities, this pioneering work gauges the potential for viruses to act as oncolytic and anti-tumor agents for the treatment of cancers in humans-detailing the cancer-combative properties exhibited by viruses in nature, genetically engineered viruses, and viral oncolysates as evidenced in basic and experimental studies | ||
| 655 | 0 | |a Electronic books | |
| 700 | 1 | |a Horvath, Joseph |4 oth | |
| 776 | 1 | |z 9781420030402 |c : 200.99 (NL) | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Viral Therapy of Human Cancers |
| 856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/kxp/detail.action?docID=1405275 |x Aggregator |3 Volltext |
| 889 | |w (DE-627)772548439 | ||
| 912 | |a ZDB-30-PQE | ||
| 935 | |h GBV |i ExPruef | ||
| 951 | |a BO | ||
| 992 | |a 20210218 | ||
| 999 | |a KXP-PPN79309979X |e 3858580090 | ||
| BIB | |a Y | ||
| SPR | |a Y | ||
| JSO | |a {"id":{"isbn":["9780824759131"],"eki":["79309979X"]},"origin":[{"publisher":"Taylor and Francis","dateIssuedKey":"2004","dateIssuedDisp":"2004","publisherPlace":"Hoboken"}],"title":[{"title_sort":"Viral Therapy of Human Cancers","title":"Viral Therapy of Human Cancers"}],"person":[{"given":"Joseph G.","family":"Sinkovics","role":"aut","display":"Sinkovics, Joseph G."},{"given":"Joseph","family":"Horvath","role":"oth","display":"Horvath, Joseph"}],"language":["eng"],"recId":"79309979X","physDesc":[{"extent":"Online-Ressource (848 p)"}],"type":{"bibl":"book","media":"Online-Ressource"},"note":["Description based upon print version of record"]} | ||
| SRT | |a SINKOVICSJVIRALTHERA2004 | ||